| 
| 2004 Grants |
| Investigator |
Institution |
Project Title |
Grant Duration |
Amt Granted |
| Sergei Atamas,
M.D., Ph.D. |
University of
Maryland School of Medicine
Baltimore, Md. |
The Role of PARC
in Lung Fibrosis – From In Vitro to In Vivo Research |
Two Years |
$150,000 |
| Edwin Chan, M.B., Ch.B. |
New York University School
of Medicine
New York, N.Y. |
Purinergic Modulation of
Dermal Fibrosis |
One Year |
$50,000 |
| Susan Croll, Ph.D. |
Queens College – CUNY
Flushing, N.Y. |
Inflammation Induced by Sympathetic
Overactivation: Evaluation of a Potential Animal Model
for Scleroderma Features and Etiology |
One Year |
$50,000 |
| Asish Ghosh, Ph.D. |
University of Illinois at
Chicago, Chicago, Ill. |
Repression of TGF-ß
Signaling by PPAR-?: Novel Approach to Controlling Fibrosis |
Two Years |
$150,000 |
| Richard Gomer, Ph.D. |
Rice University
Houston, TX |
Testing Serum Amyloid P as
a Diagnostic and Therapeutic |
Two Years |
$150,000 |
| Robert Lafyatis, M.D. |
Boston University Medical
Center, Boston, Mass. |
Fibrillin-binding Matrix
and BMPs in TSK Mice and Scleroderma |
Two Years |
$150,000 |
| Irina Luzina, M.D., Ph.D. |
Baltimore VA Medical Center,
Baltimore, Md. |
G-Protein-Coupled Signaling
From PARC Receptor in Lung Fibroblasts |
Three Years |
$150,000 |
| Karen Lyons, Ph.D. |
University of California
Los Angeles, Calif. |
CTGF in Scleroderma |
Two Years |
$150,000 |
| Yasuji Mori, M.D., Ph.D. |
University of Illinois at
Chicago, Chicago, Ill. |
Modulation of Fibrotic Responses
by a Novel TGF-ß Receptor Kinase Inhibitor in Vitro
and in Vivo |
Two Years |
$150,000 |
| Elena Tourkina, Ph.D. |
Medical University of South
Carolina
Charleston, S.C. |
Caveolin-1 in Scleroderma
Lung Disease |
Two Years |
$150,000 |
| Xiadong Zhou, M.D. |
University of Texas Health Science Center
Houston, TX |
Regulation of SPARC & CTGF in Scleroderma
Fibroblasts |
Three Years |
$150,000 |
| |
|
Total Granted 2004: |
|
$1,450,000 |
|
